BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2954110)

  • 1. [An unrecognized cause of allergic eczema of the face: a corticoid, tixocortol pivalate].
    Foussereau J; Jelen G
    Presse Med; 1987 May; 16(17):832. PubMed ID: 2954110
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone.
    Lauerma AI
    Contact Dermatitis; 1991 Feb; 24(2):123-30. PubMed ID: 1828209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short induction phase of contact allergy to tixocortol pivalate in a nasal spray.
    Bircher AJ
    Contact Dermatitis; 1990 Apr; 22(4):237-8. PubMed ID: 2140756
    [No Abstract]   [Full Text] [Related]  

  • 4. The significance of tixocortol-pivalate-positive patch tests in leg ulcer patients.
    Wilkinson M; Cartwright P; English JS
    Contact Dermatitis; 1990 Aug; 23(2):120-1. PubMed ID: 2145125
    [No Abstract]   [Full Text] [Related]  

  • 5. Contact stomatitis from tixocortol pivalate.
    Callens A; Vaillant L; Machet L; Pelucio-Lopez C; de Calan S; Lorette G
    Contact Dermatitis; 1993 Sep; 29(3):161. PubMed ID: 8222636
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydrocortisone sensitivity. An investigation into the nature of the allergen.
    Wilkinson SM; English JS
    Contact Dermatitis; 1991 Sep; 25(3):178-81. PubMed ID: 1838313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid contact hypersensitivity: what vehicle and concentration?
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1996 May; 34(5):305-8. PubMed ID: 8807220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity of tixocortol pivalate-positive patients in intradermal and oral provocation tests.
    Räsänen L; Tuomi ML; Ylitalo L
    Br J Dermatol; 1996 Dec; 135(6):931-4. PubMed ID: 8977714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact hypersensitivity to tixocortol pivalate.
    Lutz ME; el-Azhary RA; Gibson LE; Fransway AF
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guinea pig maximization test assessment of hydrocortisone and tixocortol pivalate.
    Mirshahpanah P; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):375-82. PubMed ID: 18058310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic contact dermatitis induced by topical hydrocortisone butyrate propionate mimicking acute generalized exanthematous pustulosis.
    TOHGI N; ETO H; MAEJIMA H; SAITO N; NAKAMURA M; KATSUOKA K
    Eur J Dermatol; 2009; 19(5):518-9. PubMed ID: 19527994
    [No Abstract]   [Full Text] [Related]  

  • 12. Probable active sensitization to tixocortol pivalate.
    Goldsmith PC; White IR; Rycroft RJ; McFadden JP
    Contact Dermatitis; 1995 Dec; 33(6):429. PubMed ID: 8706404
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contact allergy to topical glucocorticoids].
    Dooms-Goossens A
    Hautarzt; 1994 Mar; 45(3):196. PubMed ID: 8175354
    [No Abstract]   [Full Text] [Related]  

  • 14. Allergic reactions to topical corticosteroids or their vehicles.
    Fisher AA
    Cutis; 1983 Aug; 32(2):122, 129-32, 137. PubMed ID: 6225625
    [No Abstract]   [Full Text] [Related]  

  • 15. Contact hypersensitivity to hydrocortisone-free-alcohol in patients with allergic patch test reactions to tixocortol pivalate.
    Lauerma AI; Tarvainen K; Forström L; Reitamo S
    Contact Dermatitis; 1993 Jan; 28(1):10-4. PubMed ID: 8428438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patch-testing with serial dilutions of tixocortol pivalate and potential cross-reactive substances.
    Isaksson M; Bruze M; Goossens A; Lepoittevin JP
    Acta Derm Venereol; 2000; 80(1):33-8. PubMed ID: 10721831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide.
    Chowdhury MM; Statham BN; Sansom JE; Foulds IS; English JS; Podmore P; Bourke J; Orton D; Ormerod AD
    Contact Dermatitis; 2002 May; 46(5):311-2. PubMed ID: 12084094
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations.
    Shaw DW; Maibach HI
    Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patch test results with tixocortol pivalate and budesonide in Germany and Austria.
    Uter W; Geier J; Richter G; Schnuch A;
    Contact Dermatitis; 2001 May; 44(5):313-4. PubMed ID: 11380156
    [No Abstract]   [Full Text] [Related]  

  • 20. A survey of the results of patch tests with tixocortol pivalate.
    Dooms-Goossens A; Andersen KE; Burrows D; Camarasa JG; Ducombs G; Frosch PJ; Lachapelle JM; Lahti A; Menné T; Rycroft RJ
    Contact Dermatitis; 1989 Feb; 20(2):158. PubMed ID: 2706969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.